The Fontan operation, which places the systemic and pulmonary circulations in series and is driven by a single ventricular chamber, is the treatment of choice for patients born with one ventricle. Its ...
The Fontan procedure has saved the lives of many people born with only one ventricle, but their unique circulatory system requires lifelong medical monitoring and care. A new scientific statement ...
Pediatric heart specialists in the Single Ventricle Care Program provide expert consultation and treatment of the unique issues that arise after the Norwood, Glenn and Fontan operations. For example, ...
In the current issue of Cardiovascular Innovations and Applications (Volume3, Number 1, 2018, pp. pp. 107-122(X); DOI: 10.15212/CVIA.2017.0041, researchers Ahmed Kheiwa, Anushree Agarwal and Anitha ...
Dr Julian Alexander Härtel and Dr Nicole Müller from the Department of Paediatric Cardiology at the UKB, who jointly led the study, with study nurse and coordinator Ute Baur. The researchers conducted ...
SEOUL, South Korea, April 16, 2025 /PRNewswire/ -- Mezzion Pharmaceuticals, a global leader in the development of therapies for patients with single ventricle heart disease, announces a transformative ...
SEOUL, South Korea, Aug. 12, 2025 /PRNewswire/ -- A newly published post-hoc analysis of the landmark FUEL (Fontan Udenafil Exercise Longitudinal) Trial demonstrates that udenafil, a PDE5 inhibitor, ...
The Fontan operation is now among the most common procedures performed to treat complex congenital cardiac defects not amenable to biventricular repair. The advent of the Norwood procedure to treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback